Legend Biotech (LEGN) Inventory Average (2020 - 2026)

Legend Biotech (LEGN) has 7 years of Inventory Average data on file, last reported at $34.6 million in Q1 2026.

• Quarterly Inventory Average rose 26.02% year-over-year to $34.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.6 million (up 26.02% YoY) and the FY2025 annual result came in at $28.0 million, up 29.0% from the prior year.
• Inventory Average improved to $34.6 million in Q1 2026, from $30.6 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $34.6 million in Q1 2026 to a low of $2.3 million in Q1 2022.
• A 5-year average of $21.9 million and a median of $21.0 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average jumped 385.14% — and 2026, when it increased 26.02%.
• Tracing LEGN's Inventory Average over 5 years: stood at $2.3 million in 2022, then soared by 706.35% to $18.7 million in 2023, then rose by 26.71% to $23.7 million in 2024, then increased by 28.95% to $30.6 million in 2025, then rose by 12.94% to $34.6 million in 2026.
• The last three Inventory Average figures came in at $34.6 million (Q1 2026), $30.6 million (Q4 2025), and $32.4 million (Q3 2025), per Business Quant data.